Tumor cyclooxygenase 2-dependent suppression of dendritic cell function

Clinical Cancer Research

Volumn 9, Issue 3, 2003, Pages 961-968

  Sharma, Sherven ^a   Stolina, Marina ^a   Yang, Seok Chul ^a   Baratelli, Felicita ^a   Lin, Jeff F ^a   Atianzar, Kimberly ^a   Luo, Jie ^a   Zhu, Li ^a   Lin, Ying ^a   Huang, Min ^a   Dohadwala, Mariam ^a   Batra, Raj K ^a   Dubinett, Steven M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; B7 ANTIGEN; CD86 ANTIGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR PROTEIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG EFFECT; IMMUNE SYSTEM; IN VITRO STUDY; LUNG CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERNATANT; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; BLOTTING, WESTERN; CYCLOOXYGENASE 2; CYTOPLASM; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-12; ISOENZYMES; LUNG NEOPLASMS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDES; PHENOTYPE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037343236     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Herschman, H. Review: prostaglandin synthase 2. Biochim. Biophys. Acta, 1299: 125-140, 1996.
2. Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., and Koki, A. T. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer (Phila.), 89: 2637-2645, 2000.
3. Huang, M., Stolina, M., Sharma, S., Mao, J., Zhu, L., Miller, P., Wollman, J., Herschman, H., and Dubinett, S. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res., 58: 1208-1216, 1998.
4. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K-i., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cycloxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58: 3761-3764, 1998.
5. Tsujii, M., and Dubois, R. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell, 83: 493-501, 1995.
6. Dohadwala, M., Luo, J., Zhu, L., Lin, Y., Dougherty, G., Sharma, S., Huang, M., Pold, M., Batra, R., and Dubinett, S. Non small cell lung cancer cylooxygenase-2-dependent invasion is mediated by CD44. J. Biol. Chem., 276: 20809-20812, 2001.
7. Leahy, K., Koki, A., and Masferrer, J. Role of cyclooxygenases in angiogenesis. Curr. Med. Chem., 7: 1163-1170, 2000.
8. Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., Lee, J. C., and Dubinett, S. M. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol., 164: 361-370, 2000.
9. Tsujii, M., Kawano, S., and DuBois, R. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
10. Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Wash. DC), 264: 961-965, 1994.
11. Banchereau, J., and Steinman, R. M. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-252, 1998.
12. Almand, B., Resser, J. R., Lindman, B., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., and Gabrilovich, D. I. Clinical significance of defective dendritic cell differentiation in cancer. Clin. Cancer Res., 6: 1755-1766, 2000.
13. Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., and Carbone, D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med., 2: 1096-1103, 1996.
14. Alavena, P., Piemonti, L., Longoni, D., Bernasconi, S., Stoppacciaro, A., Ruco, L., and Mantovani, A. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol., 28: 359-363, 1998.
15. Caux, M., Montmain, C. G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., and Blay, J. Y. Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin 6 and macrophage colony stimulating factor. Blood, 92: 4778-4791, 1998.
16. Sharma, S., Stolina, M., Lin, Y., Gardner, B., Miller, P. W., Kronenberg, M., and Dubinett, S. M. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J. Immunol., 163: 5020-5028, 1999.
17. Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., and Eisenbach, L. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.), 369: 67-71, 1994.
18. Kiertscher, S. M., Luo, J., Dubinett, S. M., and Roth, M. D. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol., 164: 1269-1276, 2000.
19. Pulaski, B., Yeh, K-Y., Shastri, N., Maltby, K., Penney, D., Lord, E., and Frelinger, J. Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc. Natl. Acad. Sci. USA, 93: 3669-3674, 1996.
20. Chaux, P., Favre, N., Martin, M., and Martin, F. Tumor infiltrating dendritic cells are defective in their antigen presenting function and inducible B7 expression in rats. Int. J, Cancer, 72: 619-624, 1997.
21. Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., and Carbone, D. P. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res., 3: 483-490, 1997.
22. Troy, A. J., Summers, K. L., Davidson, P. J., Atkinson, C. H., and Hart, D. N. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin. Cancer Res., 4: 585-593, 1998.
23. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J. Immunol., 157: 5512-5520, 1996.
24. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol., 161: 2723-2730, 1998.
25. 2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL12p70 heterodimer. Blood, 97: 3466-3469, 2001.
26. 2 that regulate cellular immune responses in the mouse. J. Clin. Investig., 108: 1229-1235, 2001.
27. Pamer, E., and Cresswell, P. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol., 16: 323-358, 1998.
28. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell, 78: 761-771, 1994.
29. Androlewicz, M. J., Anderson, K. S., and Cresswell, P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl. Acad. Sci. USA, 90: 9130-9134, 1993.
30. Hill, A., and Ploegh, H. Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. Proc. Natl. Acad. Sci. USA, 92: 341-343, 1995.
31. Pettit, A., Quinn, C., MacDonald, K., Cavanagh, L., Thomas, G., Townsend, W., Handel, M., and Thomas, R. Nuclear localization of Re?B is associated with effective antigen-presenting cell function. J. Immunol., 159: 3681-3691, 1997.
32. Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D., and Gabrilovich, D. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells. J. Immunol., 160: 1224-1232, 1998.
33. 2, promote Th2 responses. Adv. Exp. Med. Biol., 417: 363-367, 1997.
34. 2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med., 186: 1603-1608, 1997.
35. 2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol., 161: 2804-2809, 1998.
36. 2 that contributes to the immunomodulation induced by antigen-presenting cells. Cell. Immunol., 209: 19-28, 2001.
37. Corinti, S., Albanesi, C., Sala, A. L., Pastore, S., and Girolomoni, G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol., 166: 4312-4318, 2001.
38. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J., and Enk, A. H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol., 159: 4772-4780, 1997.
39. Khuri, F., Wu, H., Lee, J., Kemp, B., Lotan, R., Lippman, S., Feng, L., Hong, W., and Xu, X-C. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin. Cancer Res., 7: 861-867, 2001.
40. Achiwa, H., Yatabe, Y., Hida, T., Kuroishi, T., Kozaki, K., Nakamura, S., Ogawa, M., Sugiura, T., Mitsudomi, T., and Takahashi, T. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin. Cancer Res., 5: 1001-1005, 1999.
41. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.